Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Bayer's (BAYRY) Q3 Earnings Miss Estimates, Revenues Top
03:40pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Bayer's (BAYRY) earnings fall shy of estimates in the third quarter of 2022 while revenues beat the same.
These 3 Dividend ETFs Are a Retiree's Best Friend
12:30pm, Tuesday, 08'th Nov 2022 The Motley Fool
This trio of exchange-traded funds has trounced the S&P 500 this year.
The Zacks Analyst Blog Highlights Merck, ConocoPhillips, Adobe, Intercontinental Exchange and Monster Beverage
10:31am, Tuesday, 08'th Nov 2022 Zacks Investment Research
Merck, ConocoPhillips, Adobe, Intercontinental Exchange and Monster Beverage are included in this Analyst Blog.
Top Research Reports for Merck, ConocoPhillips & Adobe
09:14pm, Monday, 07'th Nov 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), ConocoPhillips (COP) and Adobe Inc. (ADBE).
5 Relatively Safe And Cheap Dividend Stocks To Invest In - November 2022
01:00pm, Saturday, 05'th Nov 2022 Seeking Alpha
Check out our monthly series where we highlight 5 companies that are large-cap, relatively safe, dividend-paying and offering large discounts.
Rose's Income Garden Portfolio October Update: Outperforms SPY 17.3%, Yield 5.2%
07:43am, Friday, 04'th Nov 2022 Seeking Alpha
RIG value/ total return perked up to just off 0.45% while outperforming SPY by ~17.3%. Read why end of 2022 and into 2023 should offer better opportunities.
Moderna's (MRNA) Lags on Q3 Earnings, Lowers '22 Sales Outlook
05:29pm, Thursday, 03'rd Nov 2022 Zacks Investment Research
Moderna's (MRNA) third-quarter earnings miss expectations, while sales narrowly beat the mark. Shares declined in pre-market trading after management announced a guidance cut in COVID vaccine sales.
The 7 Best Retirement Stocks to Buy After Age 50
05:20pm, Thursday, 03'rd Nov 2022
Some may believe that the best retirement stocks for investors over 50 are all ultra-conservative names with relatively high dividend yields, but one well-known investment advisory firm suggests that'
Allogene (ALLO) Reports Narrower-Than-Expected Loss in Q3
05:16pm, Thursday, 03'rd Nov 2022 Zacks Investment Research
Allogene's (ALLO) third-quarter earnings beat estimates, but sales miss the mark. ALLO will host an R&D showcase later this month and discuss updated clinical data on its pipeline candidates.
Moderna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion
04:45pm, Thursday, 03'rd Nov 2022 MarketWatch
Moderna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings and lowered full-year sales guidance by up to $3 billion.
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Wednesday, 02'nd Nov 2022
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Got $3,000? Here Are 3 Stocks to Buy and Hold for the Long Term
05:25am, Tuesday, 01'st Nov 2022
Great companies grow their top and bottom lines, but they also plug into trends rooted in cultural change, consumer convenience, and practicality.
Merck (MRK) Upgraded to Buy: Here's Why
01:33pm, Monday, 31'st Oct 2022
Merck (MRK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Final Trades: Merck, Defense, Clearway Energy & more
02:31pm, Thursday, 27'th Oct 2022
The "Halftime Report" traders give their top picks to watch for the second half.
